The reported incidence of activated EGFR in HNSCC tumors and cell lines varies from 5% to 90% [16, 17], however, suggesting that STAT3 activation in HNSCC may occur independently of EGFR activation. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.